PDL BioPharma, Inc. ( PDLI ) will begin trading ex-dividend on June 03, 2014. A cash dividend payment of $0.15 per share is scheduled to be paid on June 12, 2014. Shareholders who purchased PDLI stock prior to the ex-dividend date are eligible for the cash dividend payment. This marks the 16th quarter that PDLI has paid the same dividend. At the current stock price of $9.37, the dividend yield is 6.4%.
The previous trading day's last sale of PDLI was $9.37, representing a -8.18% decrease from the 52 week high of $10.21 and a 26.96% increase over the 52 week low of $7.38.
PDLI is a part of the Health Care sector, which includes companies such as Gilead Sciences, Inc. ( GILD ) and Amgen Inc. ( AMGN ). PDLI's current earnings per share, an indicator of a company's profitability, is $1.81. Zacks Investment Research reports PDLI's forecasted earnings growth in 2014 as 24.1%, compared to an industry average of 11.9%.
For more information on the declaration, record and payment dates, visit the PDLI Dividend History page. Our Dividend Calendar has the full list of stocks that have an ex-dividend today.
Interested in gaining exposure to PDLI through an Exchange Traded Fund [ETF]?
The following ETF(s) have PDLI as a top-10 holding:
- First Trust DJ Global Select Dividend ( FGD )
- WisdomTree SmallCap Earnings Fund ( EES )
- WisdomTree Trust SmallCap Dividend Fund ( DES ).
The top-performing ETF of this group is FGD with an increase of 9.76% over the last 100 days. It also has the highest percent weighting of PDLI at 1.28%.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.